ReviewRevista medica del Instituto Mexicano del Seguro Social2024
[Dual kidney transplantation, report of a case and review of the literature].
Review in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kidney transplant is the best replacement therapy for kidney function; However, donors are insufficient, so extended criteria donors (ECD) are needed, which, in well-selected recipients, provide better survival than being on dialysis. Dual kidney transplantation (DRT) should be offered to elderly patients with lower immunological risk and with a lower body mass index. DCE are considered donors who died due to stroke, ≥ 60 years old or aged between 50 and 59 years, with diabetes or previous hypertension, clinical proteinuria, estimated glomerular filtration rate (eGFR) between 30 and 60 mL/min, or Terminal serum creatinine > 2.5 mg/dL. Clinical case: 57-year-old male patient undergoing TRD of a 67-year-old DCE, with creatinine of 2 mg/dL at the time of extraction, without previous pathologies, with eGFR: 34 mL/min, KDPI: 92% , KDRI: 1.64, Remuzzi pre-implantation biopsy 5, with 14-hour cold ischemia. He was discharged on the eighth day with a creatinine of 1 mg/dL. At 45 months with creatinine of 0.9 mg/dL, and eGFR by CKD-EPI of 91 mL/min/ 1.73m2. Conclusion: TRD is an alternative for ECD grafts. The "old for old" strategy allows TRD in older recipients a better survival than being on replacement treatment. The correlation with the KDRI, KDPI scales and the preimplantation biopsy according to the Remuzzi score improves transplant results by discarding kidneys with severe histopathological alterations, this can help reduce the rate of discarding SCAD and kidneys.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.